NeOnc Technologies (Series A)

Funding Details
Awarder
Inbox
Date Award
February 08, 2023
Vertical
Biotechnology
Funding URL
View Funding Page
Valuation
$70,000,000
Funding Amount:
$10,000,000

Company Info
Founders
Thomas Chen
Company Description
NeOnc Technologies develops intranasal inhalation dosing therapies for the treatment of brain and lung cancers.
Market
Pharmaceuticals and therapeutics for brain and central nervous system diseases
Location
Los Angeles, CA, USA
Coinvestors
Eminent II Venture Capital, Lin Family Office, Orion BioScience

Links